2021年1月14日，国家卫生院校Covid-19治疗指南小组修订了伊维菌蛋白对伊维菌蛋白的偏离标签使用来治疗2019年（Covid-19）的立场，从“反对”到“反对”而不是为了反对“。Ivermectin is approved by the U.S. Food and Drug Administration (FDA) for use in humans by prescription only as an oral treatment for some parasitic worms (intestinal strongyloidiasis and onchocerciasis) and as a topical to treat external parasites such as head lice and for skin conditions such as rosacea. The NIH panel recommendation of “neither for nor against” is the same . . .

---

标记为：

• 医疗系统
• 全世界